All prices are in US$. Prices are given both for a yearly adult dose and by unit.
For details on eligibility and offer restrictions for countries and institutions, please refer to table 2a.
Products on the WHO list of Pilot Procurement, Quality and Sourcing Project: Access to HIV/AIDS drugs and diagnostics of acceptable quality (Sixth edition, 5th May 2003) are in bold and have an asterisk* next to the price. Always check website for most recently updated list. Best prices are in bold & underlined. Incoterms vary according to manufacturers.
Annual cost is calculated according to the daily doses given in the WHO ‘Scaling-up Antiretroviral Therapy in Resource Limited Settings: Guidelines for a Public Health Approach’ (June 2002) and/or the ‘Guidelines for the Use of Antiretroviral Agents in HIV-Infected Adults and Adolescents’ from the Panel on Clinical Practices for the Treatment of HIV (2002).
NRTI
(Abbreviation) |
abacavir
(ABC) |
didanosine
(ddI) |
didanosine
(ddI) |
lamivudine
(3TC) |
lamivudine
(3TC) |
stavudine
(d4T) |
stavudine
(d4T) |
zidovudine
(ZDV or AZT) |
Strength (mg) |
300 |
100 (§) |
EC 400 |
150 |
300 |
30 |
40 |
300 |
Trade name
Europe/US |
Ziagen®
(GSK) |
Videx®
(BMS) |
Videx®
(BMS) |
Epivir®
(GSK) |
Epivir®
(GSK) |
Zerit®
(BMS) |
Zerit®
(BMS) |
Retrovir®
(GSK) |
Daily dose |
2 |
4 |
1 |
2 |
1 |
2 |
2 |
2 |
BMS
(US) |
|
310*
(0.212/unit) |
Not applicable |
|
|
49*
(0.066/unit) |
55*
(0.075/unit) |
|
GSK
(UK) |
986*
(1.350/unit) |
|
|
128*
(0.175/unit) |
|
|
|
274*
(0.375/unit) |
Aurobindo
(India) |
|
197
(0.135/unit) |
|
66
(0.090/unit) |
|
|
31
(0.043/unit) |
140
(0.192/unit) |
Cipla
(India) |
821
(1.125/unit) |
426
(0.292/unit) |
271
(0.741/unit) |
126*
(0.172/unit) |
124
(0.340/unit) |
48
(0.065/unit) |
53
(0.072/unit) |
198*
(0.271/unit) |
GPO
(Thailand) |
|
650
(0.445/unit) |
|
163
(0.223/unit) |
|
|
73
(0.100/unit) |
277
(0.380/unit) |
Hetero
(India) |
1325
(1.815/unit) |
185
(0.127/unit) |
|
65
(0.089/unit) |
|
|
31
(0.042/unit) |
175
(0.240/unit) |
Ranbaxy
(India) |
|
|
335
(0.917/Unit) |
100*
(0.137/unit) |
|
36
(0.049/unit) |
47
(0.064/unit) |
180*
(0.246/unit) |
Combinopharm
(Spain) |
|
|
|
|
|
|
|
292*
(0.400/unit) |
(§) BMS sells ddI (Videx®) in other doses (per mg price remains the same)
Loading...
